Applied Pharmacology Research Laboratories, Drug Discovery Research, Astellas Pharma Inc., Osaka, Japan.
Skin Pharmacol Physiol. 2009;22(5):240-7. doi: 10.1159/000235551. Epub 2009 Aug 18.
Although many mouse models of atopic dermatitis have been reported, few rat models have been studied. In this study, a rat chronic allergic dermatitis model was developed and evaluated as a pharmacological model of atopic dermatitis. Prominent ear thickening and scratching were induced after the application of 2,4-dinitrochlorobenzene to the right ear of Brown Norway rats 3 times per week for 3 weeks. Histopathologically, infiltration of T cells in the ear was observed on day 7, and eosinophils and mast cells were found in addition to T cells on day 21. The expression of interferon-gamma and interleukin-4 was increased on day 7 when compared with normal rats. However, interferon-gamma expression had disappeared by day 21. Tacrolimus ointment applied after ear tissue thickening fully developed, suppressed chronic dermatitis in a dose-dependent manner. This model has some symptomatic and histopathological similarities to atopic dermatitis and might be useful in pharmacological studies.
尽管已经报道了许多特应性皮炎的小鼠模型,但很少有大鼠模型被研究过。在这项研究中,建立并评估了一种大鼠慢性过敏性皮炎模型,作为特应性皮炎的药理学模型。每周 3 次在右耳涂抹 2,4-二硝基氯苯 3 周后,会引起明显的耳部增厚和搔抓。组织病理学观察发现,第 7 天耳部有 T 细胞浸润,第 21 天除 T 细胞外还可见嗜酸性粒细胞和肥大细胞。与正常大鼠相比,第 7 天干扰素-γ和白细胞介素-4的表达增加,但第 21 天干扰素-γ的表达已经消失。在耳部组织增厚完全发展后应用他克莫司软膏,可呈剂量依赖性抑制慢性皮炎。该模型在某些症状和组织病理学方面与特应性皮炎相似,可能有助于药理学研究。